Neumora Therapeutics Announces IND Clearance and Initiation of Phase 1 Study of NMRA-266

Monday, November 27, 2023 1 min read

Key Takeaway: Neumora Therapeutics Announces IND Clearance and Initiation of Phase 1 Study of NMRA-266

Full Press Release Details

Neumora Therapeutics Announces IND Clearance and Initiation of Phase 1 Study of NMRA-266.